DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production - PubMed (original) (raw)
doi: 10.1189/jlb.0608352. Epub 2008 Nov 21.
Affiliations
- PMID: 19028959
- DOI: 10.1189/jlb.0608352
DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production
Friederike Meyer-Wentrup et al. J Leukoc Biol. 2009 Mar.
Abstract
C-type lectin receptors (CLRs) expressed on APCs play a pivotal role in the immune system as pattern-recognition and antigen-uptake receptors. In addition, they may signal directly, leading to cytokine production and immune modulation. To this end, some CLRs, like dectin-1 and dendritic cell immunoreceptor (DCIR), contain intracellular ITIMs or ITAMs. In this study, we explored expression and function of the ITIM-containing CLR DCIR on professional APCs. DCIR is expressed on immature and mature monocyte-derived DCs (moDC) but also on monocytes, macrophages, B cells, and freshly isolated myeloid and plasmacytoid DCs. We show that endogenous DCIR is internalized efficiently into human moDC after triggering with DCIR-specific mAb. DCIR internalization is clathrin-dependent and leads to its localization in the endo-/lysosomal compartment, including lysosome-associated membrane protein-1+ lysosomes. DCIR triggering affected neither TLR4- nor TLR8-mediated CD80 and CD86 up-regulation. Interestingly, it did inhibit TLR8-mediated IL-12 and TNF-alpha production significantly, and TLR2-, TLR3-, or TLR4-induced cytokine production was not affected. Collectively, the data presented characterize DCIR as an APC receptor that is endocytosed efficiently in a clathrin-dependent manner and negatively affects TLR8-mediated cytokine production. These data provide further support to the concept of CLR/TLR cross-talk in modulating immune responses.
Similar articles
- Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, Punt CJ, Figdor CG, de Vries IJ, Adema GJ. Meyer-Wentrup F, et al. Blood. 2008 Apr 15;111(8):4245-53. doi: 10.1182/blood-2007-03-081398. Epub 2008 Feb 7. Blood. 2008. PMID: 18258799 - Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, O'Bar A, Agouna-Deciat O, Klucar P, Thompson-Snipes L, Zurawski S, Reiter Y, Palucka AK, Zurawski G, Banchereau J. Klechevsky E, et al. Blood. 2010 Sep 9;116(10):1685-97. doi: 10.1182/blood-2010-01-264960. Epub 2010 Jun 7. Blood. 2010. PMID: 20530286 Free PMC article. - Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2.
Kanazawa N, Tashiro K, Miyachi Y. Kanazawa N, et al. Immunobiology. 2004;209(1-2):179-90. doi: 10.1016/j.imbio.2004.03.004. Immunobiology. 2004. PMID: 15481152 Review. - DCIR negatively regulates CpG-ODN-induced IL-1β and IL-6 production.
Zhao X, Shen Y, Hu W, Chen J, Wu T, Sun X, Yu J, Wu T, Chen W. Zhao X, et al. Mol Immunol. 2015 Dec;68(2 Pt C):641-7. doi: 10.1016/j.molimm.2015.10.007. Epub 2015 Oct 26. Mol Immunol. 2015. PMID: 26514427 - Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
Kanazawa N. Kanazawa N. J Dermatol Sci. 2007 Feb;45(2):77-86. doi: 10.1016/j.jdermsci.2006.09.001. Epub 2006 Oct 13. J Dermatol Sci. 2007. PMID: 17046204 Review.
Cited by
- Harnessing human plasmacytoid dendritic cells as professional APCs.
Tel J, van der Leun AM, Figdor CG, Torensma R, de Vries IJ. Tel J, et al. Cancer Immunol Immunother. 2012 Aug;61(8):1279-88. doi: 10.1007/s00262-012-1210-z. Cancer Immunol Immunother. 2012. PMID: 22294456 Free PMC article. Review. - Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation.
Luo X, Chen J, Yang H, Hu X, Alphonse MP, Shen Y, Kawakami Y, Zhou X, Tu W, Kawakami T, Wan M, Archer NK, Wang H, Gao P. Luo X, et al. JCI Insight. 2022 Mar 8;7(5):e152559. doi: 10.1172/jci.insight.152559. JCI Insight. 2022. PMID: 35113811 Free PMC article. - The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics.
Muslimov A, Tereshchenko V, Shevyrev D, Rogova A, Lepik K, Reshetnikov V, Ivanov R. Muslimov A, et al. Int J Mol Sci. 2023 Oct 1;24(19):14820. doi: 10.3390/ijms241914820. Int J Mol Sci. 2023. PMID: 37834268 Free PMC article. Review. - C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection.
Stoff M, Ebbecke T, Ciurkiewicz M, Pavasutthipaisit S, Mayer-Lambertz S, Störk T, Pavelko KD, Baumgärtner W, Jung K, Lepenies B, Beineke A. Stoff M, et al. Sci Rep. 2021 Dec 10;11(1):23819. doi: 10.1038/s41598-021-03201-2. Sci Rep. 2021. PMID: 34893671 Free PMC article. - C-type lectin receptor CLEC4A2 promotes tissue adaptation of macrophages and protects against atherosclerosis.
Park I, Goddard ME, Cole JE, Zanin N, Lyytikäinen LP, Lehtimäki T, Andreakos E, Feldmann M, Udalova I, Drozdov I, Monaco C. Park I, et al. Nat Commun. 2022 Jan 11;13(1):215. doi: 10.1038/s41467-021-27862-9. Nat Commun. 2022. PMID: 35017526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous